Korea to Revolutionize the Healthcare Sector with its Ultra-advanced Tech Project

Announcement

The Korean government has initiated a $16 million multimodal medical AI project across 14 private and public organizations. By far, 47 huge hospitals are in alliance with Korea’s EMR. Following this, South Koreans will have access to the medical records from the huge hospitals through the mobile health information highway application. This month, the region's Ministry of Health and Welfare will be heading towards the completion of connecting all 47 tertiary general hospitals in the country through the ‘my healthway’ application.

This mobile application helps Koreans with the knowledge and updates of their diagnoses, view imaging and pathology results, allergies, surgical records, and medications. It also allows them to manage health checkup results and children’s immunization schedules. It also enables to fetching of live information on the nearby 24-hour pharmacies and hospitals. The government predicts 1264 connections to healthcare settings by the end of August, consisting of clinics and general hospitals, to the national health record system.

Korea’s $16M Multimodal Medical AI Project (MMAP)

The South Korean government has indulged in a new 22 billion won ($16 million) medical AI research project, developing and advancing multimodal models. The MMAIP project focuses on integrating documents, voice data, and imaging in all institutions via a safe joint learning to generate a domestic medical large language model, sharpening the Korean health system. It includes 14 partners, involving Naver Cloud, Public-AI, Emocog, and Coreline, with eight other hospitals like Seoul National University Hospital and Bundang Cha Hospital, and universities such as Korea Advanced Institute of Science and Technology and Ulsan.

This year, Seoul National University Hospital unveiled Korea’s first medical LLM. Also, the Ministry of Health has introduced a task force to develop a roadmap for implementing AI in welfare and care services. This task force might be released next year.

NUS and SGH Deployed Korean Brain Imaging AI

Neurophet, a South Korean medical imaging AI company, will offer its brain imaging AI software to the Singapore General Hospital (SGH) and the National University of Singapore (NUS) to align with brain disease research. Its software merges MRI and PET data to directly quantify biomarkers, developing leveraged uptake value ratios for tracers like dopamine, tau proteins, amyloid beta, and FDG to connect Alzheimer's disease.

With the product supply, the two institutions were convinced to allow Neurophet use in their MRI and PET data to examine, validate, and support the marketization of its technology. With this supply deal with SGH and NUS Co-CEO Jake Junkil been of neurophet plans to elevate its expansion into southeast Asia.